KALV Stock Analysis: Buy, Sell, or Hold?
KALV - KalVista Pharmaceuticals, Inc. Common Stock
$15.61
-0.04 (-0.26%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Get Alerted When KALV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: KALV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: KALV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: KALV is currently trading at $15.61, which is considered fair relative to its 30-day fair value range of $15.07 to $16.15.
Technical Outlook: Technically, KALV is in a strong uptrend. Immediate support is located at $14.22, while resistance sits at $16.65.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Implied Volatility is high (79th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $33.22 (+112.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KALV is in a strong uptrend. Immediate support is located at $14.22, while resistance sits at $16.65.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Implied Volatility is high (79th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $33.22 (+112.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$15.07 -
$16.15
Company Quality Score
56/100
(HOLD)
Options IV Signal
79th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
59.2%
Protect Your Profits
Holding KALV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Options expensive (IV 79th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 112.3% below Wall St target ($33.22)
Fair Price Analysis
30-Day Fair Range
$15.07 -
$16.15
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$3.31
(21.2%)
Support & Resistance Levels
Support Level
$14.22
Resistance Level
$16.65
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-5.61
Wall Street Target
$33.22
(+112.3%)
Revenue Growth (YoY)
30.7%
Last updated: January 30, 2026 5:40 PM ET
Data refreshes hourly during market hours. Next update: 6:40 PM
Data refreshes hourly during market hours. Next update: 6:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KALV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Benjamin L Palleiko
SELL
7294 shares
2025-09-08
Nicole Sweeny
SELL
1480 shares
2025-08-25
Paul K Audhya
SELL
2336 shares
2025-08-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
Advanced KALV Option Strategies
Professional options setups generated by AI based on today's KALV price and gamma walls.
